Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
Henry Ford Hospital
mi
from
Detroit, MI
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
Missouri Heart Center
mi
from
Columbia, MO
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
Missouri Heart Center
mi
from
Columbia, MO
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
St. Luke's Mid America Heart Institute
mi
from
Kansas City, MO
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
St. Luke's Mid America Heart Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
VA North Texas Healthcare System
mi
from
Dallas, TX
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
VA North Texas Healthcare System
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
University of Washington Medical Center
mi
from
Seattle, WA
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
United Heart and Vascular Clinic and United Hospital
mi
from
Saint Paul, MN
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
United Heart and Vascular Clinic and United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
Wellspan Heart and Vascular
mi
from
York, PA
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
Wellspan Heart and Vascular
mi
from
York, PA
Click here to add this to my saved trials
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated:  1/23/2018
North Central Heart/Avera Heart Hospital
mi
from
Sioux Falls, SD
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Status: Enrolling
Updated: 1/23/2018
North Central Heart/Avera Heart Hospital
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Using Feedback Reports to Improve Medication Adherence
Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease
Status: Enrolling
Updated:  1/26/2018
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Using Feedback Reports to Improve Medication Adherence
Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease
Status: Enrolling
Updated: 1/26/2018
Philadelphia VA Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
Methods to Augment the Efficacy of Aspirin and Clopidogrel in Healthy Subjects (ASA Only) and Patients With Stable Coronary Artery Disease (Taking Clopidogrel Only) or (Taking Clopidogrel & ASA) With an Elevated Platelet Turnover (Reticulated Platelets).
Status: Enrolling
Updated:  1/29/2018
Methodist Hospital
mi
from
Houston, TX
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
Methods to Augment the Efficacy of Aspirin and Clopidogrel in Healthy Subjects (ASA Only) and Patients With Stable Coronary Artery Disease (Taking Clopidogrel Only) or (Taking Clopidogrel & ASA) With an Elevated Platelet Turnover (Reticulated Platelets).
Status: Enrolling
Updated: 1/29/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Status: Enrolling
Updated:  1/29/2018
Methodist Hospital
mi
from
Houston, TX
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole
Status: Enrolling
Updated: 1/29/2018
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Yuma Regional Medical Center
mi
from
Yuma, AZ
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Yuma Regional Medical Center
mi
from
Yuma, AZ
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Mission Cardiovascular Research Institute
mi
from
Fremont, CA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Mission Cardiovascular Research Institute
mi
from
Fremont, CA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Good Samaritan Hospital Los Angeles
mi
from
Los Angeles, CA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Good Samaritan Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Medical Center of the Rockies
mi
from
Loveland, CO
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Medical Center of the Rockies
mi
from
Loveland, CO
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Yale University School of Medicine
mi
from
New Haven, CT
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Cardiovascular Research of North Florida
mi
from
Gainesville, FL
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Cardiovascular Research of North Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Baptist Cardiac and Vascular Institute
mi
from
Miami, FL
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Baptist Cardiac and Vascular Institute
mi
from
Miami, FL
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Coastal Vascular & Interventional, PLLC.
mi
from
Pensacola, FL
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Coastal Vascular & Interventional, PLLC.
mi
from
Pensacola, FL
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Emory University Hospital
mi
from
Atlanta, GA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Northside Hospital
mi
from
Atlanta, GA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Advocate Health and Hospitals Corporation
mi
from
Oakbrook Terrace, IL
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Advocate Health and Hospitals Corporation
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
St. Joseph Hospital
mi
from
Fort Wayne, IN
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
St. Joseph Hospital
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Central Iowa Hospital Corporation
mi
from
Des Moines, IA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Central Iowa Hospital Corporation
mi
from
Des Moines, IA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Metro Health Hospital
mi
from
Wyoming, MI
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Jackson Heart Clinic
mi
from
Jackson, MS
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Jackson Heart Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Deborah Heart and Lung Center
mi
from
Browns Mills, NJ
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Mount Sinai Hospital
mi
from
New York, NY
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Mission Hospital, Inc
mi
from
Asheville, NC
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Rex Hospital, Inc
mi
from
Raleigh, NC
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Rex Hospital, Inc
mi
from
Raleigh, NC
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
OhioHealth Research Institute
mi
from
Columbus, OH
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
OhioHealth Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
North Ohio Research, Ltd.
mi
from
Elyria, OH
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
North Ohio Research, Ltd.
mi
from
Elyria, OH
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Jobst Vascular Institute
mi
from
Toledo, OH
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Jobst Vascular Institute
mi
from
Toledo, OH
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Heritage Valley Health System
mi
from
Beaver, PA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Heritage Valley Health System
mi
from
Beaver, PA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Pinnacle Health Cardiovascular Institute
mi
from
Wormleysburg, PA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Pinnacle Health Cardiovascular Institute
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Sanford Health Vascular Associates
mi
from
Sioux Falls, SD
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Sanford Health Vascular Associates
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
University Surgical Associates, LLC
mi
from
Chattanooga, TN
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
University Surgical Associates, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Wellmont Holston Valley Medical
mi
from
Kingsport, TN
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Wellmont Holston Valley Medical
mi
from
Kingsport, TN
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
El Paso Cardiology Associates
mi
from
El Paso, TX
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
El Paso Cardiology Associates
mi
from
El Paso, TX
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
University of Virginia
mi
from
Charlottesville, VA
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
CAMC Clinical Trial Center
mi
from
Charleston, WV
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
CAMC Clinical Trial Center
mi
from
Charleston, WV
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Aurora Health Care
mi
from
Milwaukee, WI
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Aurora Health Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated:  1/29/2018
Medical University Graz
mi
from
Graz,
ILLUMENATE Pivotal Post-Approval Study (PAS)
ProspectIve, Randomized, SingLe-Blind, U.S. MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon Pivotal Post-Approval Study
Status: Enrolling
Updated: 1/29/2018
Medical University Graz
mi
from
Graz,
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Downey, CA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials